Publications of M. Uhr
All genres
Journal Article (285)
261.
Journal Article
26, p. A177 - A177 (2003)
Influence of sleep deprivation on plasma ghrelin levels in healthy subjects. Sleep 262.
Journal Article
53 (8 Suppl.), p. 209S - 209S (2003)
Ghrelin promotes slow-wave sleep in man. Biological Psychiatry 263.
Journal Article
37 (2), pp. 135 - 143 (2003)
Association between response to lithium augmentation and the combined DEX/CRH test in major depressive disorder. Journal of Psychiatric Research 264.
Journal Article
367 (Suppl. Suppl. 1), p. R111 - R111 (2003)
Opposite changes of nocturnal ghrelin and leptin levels during treatment of depression with mirtazapine. Naunyn-Schmiedebergs Archives of Pharmacology 265.
Journal Article
28 (2), pp. 235 - 243 (2003)
Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevate behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model. Neuropsychopharmacology 266.
Journal Article
28, pp. 401 - 418 (2003)
On the role of menopause for sleep-endocrine alterations associated with major depression. Psychoneuroendocrinology 267.
Journal Article
17 (1), pp. 43 - 48 (2003)
Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression. Depression and Anxiety 268.
Journal Article
28 (2), pp. 379 - 383 (2003)
Steroid synthesis inhibition with ketoconazole and its effects upon the regulation of the hypothalamus-pituitary-adrenal system in healthy humans. Neuropsychopharmacology 269.
Journal Article
28 (11), pp. 1991 - 1999 (2003)
ABCBI (MDRI)- type P-Glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic-pituitary-adrenocortical system: implications for affective disorder. Neuropsychopharmacology 270.
Journal Article
37 (3), pp. 179 - 185 (2003)
abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice. Journal of Psychiatric Research 271.
Journal Article
54 (8), pp. 840 - 846 (2003)
Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) p-glycoprotein gene disruption. Biological Psychiatry 272.
Journal Article
114 (7), pp. 752 - 753 (2002)
Mutation analysis of genes regulating the hypothalamo-pituitary adrenal (HPA) axis in patients with depressive syndrome. American Journal of Medical Genetics 273.
Journal Article
71 (4 Suppl. Suppl. S), p. 468 - 468 (2002)
Mutation analysis of genes regulating the hypothalamo-pituitary adrenal (HPA) axis in patients with depressive syndrome. American Journal of Human Genetics 274.
Journal Article
56, pp. 1749 - 1751 (2001)
Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients. Neurology 275.
Journal Article
3, pp. 59 - 60 (2001)
Multiple Sklerose. Liquoranalyse in der MS-Diagnostik. Neurotransmitter 276.
Journal Article
35, pp. 83 - 94 (2001)
Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression: a prospective study. Journal of Psychiatric Research 277.
Journal Article
12, pp. 4331 - 4337 (2000)
Differential induction of NF-κB activity and neural cell death by antidepressants in vitro. European Journal of Neuroscience 278.
Journal Article
72, pp. 195 - 198 (2000)
Reduced leptin levels in human narcolepsy. Neuroendocrinology 279.
Journal Article
22, pp. 380 - 387 (2000)
Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to Mdr 1 a p-glycoprotein gene disruption. Neuropsychopharmacology 280.
Journal Article
156, pp. 312 - 314 (1999)
Body weight and leptin plasma levels during treatment with antipsychotic drugs. American Journal of Psychiatry